BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 10556921)

  • 1. Adrenergic and purinergic components in bisected vas deferens from spontaneously hypertensive rats.
    Guitart M; Giraldo J; Goñalons E; Vila E; Badia A
    Br J Pharmacol; 1999 Oct; 128(4):873-80. PubMed ID: 10556921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperreactivity of alpha 1-adrenoceptors, but not of P2X-purinoceptors, in vas deferens of spontaneously hypertensive rats.
    Katsuragi T; Kuratomi L; Sato C; Furukawa T
    Eur J Pharmacol; 1991 Jul; 199(3):303-7. PubMed ID: 1655481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hypophysectomy on purinergic and noradrenergic contractility of the rat vas deferens.
    Ralevic V; Burnstock G
    J Auton Pharmacol; 1996 Aug; 16(4):191-6. PubMed ID: 8953373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neocuproine, a copper (I) chelator, potentiates purinergic component of vas deferens contractions elicited by electrical field stimulation.
    Göçmen C; Kumcu EK; Büyüknacar HS; Onder S; Singirik E
    Pharmacology; 2005 Oct; 75(2):69-75. PubMed ID: 16020948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in electrophysiological properties in the prostatic portion of vas deferens from spontaneously hypertensive rats.
    Guitart M; Jiménez M; Giraldo J; Goñalons E; Badia A
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):425-30. PubMed ID: 12382071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A1 adenosine receptor modulation of electrically-evoked contractions in the bisected vas deferens and cauda epididymis of the guinea-pig.
    Haynes JM; Alexander SP; Hill SJ
    Br J Pharmacol; 1998 Jul; 124(5):964-70. PubMed ID: 9692782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the operational model of agonism and [3H]prazosin binding to assess altered responsiveness of alpha1-adrenoceptors in the vas deferens of spontaneously hypertensive rat.
    Vivas NM; Giraldo J; Tabernero A; Vila E; Badia A
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):383-91. PubMed ID: 9303577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contractility of urinary bladder and vas deferens after sensory denervation by capsaicin treatment of newborn rats.
    Ziganshin AU; Ralevic V; Burnstock G
    Br J Pharmacol; 1995 Jan; 114(1):166-70. PubMed ID: 7712013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study on contractile responses of rabbit and guinea pig vasa deferentia to electrical field stimulation.
    Nakanishi H; Ohkubo S; Ono T; Matsuoka I; Nakahata N
    Fukushima J Med Sci; 2004 Dec; 50(2):55-64. PubMed ID: 15779571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contractile responses of prostatic and epididymal portions of isolated rabbit vas deferens to electrical field stimulation.
    Nakanishi H; Matsuoka I; Nakahata N
    Fukushima J Med Sci; 2008 Jun; 54(1):4-10. PubMed ID: 18924548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of in vivo and in vitro ethanol on adrenergic and purinergic responses of the bisected rat vas deferens to low and high frequency pulses.
    Boselli C; Govoni S
    J Auton Pharmacol; 2001 Aug; 21(4):171-9. PubMed ID: 11952872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional variation in purinergic and adrenergic responses in isolated vas deferens of rat, rabbit and guinea-pig.
    Sneddon P; Machaly M
    J Auton Pharmacol; 1992 Dec; 12(6):421-8. PubMed ID: 1474107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 7-nitro indazole on neurotransmission in the rat vas deferens: mechanisms unrelated to inhibition of nitric oxide synthase.
    Allawi HS; Wallace P; Pitcher A; Gaffen Z; Bland-Ward PA; Moore PK
    Br J Pharmacol; 1994 Sep; 113(1):282-8. PubMed ID: 7529112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies.
    Ohmura T; Oshita M; Kigoshi S; Muramatsu I
    Br J Pharmacol; 1992 Nov; 107(3):697-704. PubMed ID: 1361871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The purinergic component of human vas deferens contraction.
    Banks FC; Knight GE; Calvert RC; Thompson CS; Morgan RJ; Burnstock G
    Fertil Steril; 2006 Apr; 85(4):932-9. PubMed ID: 16580377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suramin: a selective inhibitor of purinergic neurotransmission in the rat isolated vas deferens.
    Mallard N; Marshall R; Sithers A; Spriggs B
    Eur J Pharmacol; 1992 Sep; 220(1):1-10. PubMed ID: 1330614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of endothelin-1 on postjunctionally-mediated purinergic and adrenergic components of rat vas deferens contractile responses.
    Mutafova-Yambolieva V; Radomirov R
    Neuropeptides; 1993 Jan; 24(1):35-42. PubMed ID: 8429922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purinergic contraction of the rat vas deferens in L-NAME-induced hypertension: effect of sildenafil.
    Gur S; Sikka SC; Knight GE; Burnstock G; Hellstrom WJ
    Asian J Androl; 2010 May; 12(3):415-21. PubMed ID: 20305675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the purinergic contribution to sympathetic vascular responses in SHR and WKY rats in vitro and in vivo.
    Dalziel HH; Machaly M; Sneddon P
    Eur J Pharmacol; 1989 Nov; 173(1):19-26. PubMed ID: 2575039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial natriuretic peptide inhibits the purinergic and not the adrenergic component of electrically induced contractile responses in guinea pig vas deferens.
    Mutafova-Yambolieva VN; Venkova KM; Lasova LS
    J Pharmacol Exp Ther; 1993 May; 265(2):920-6. PubMed ID: 8098767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.